Matteo Amicucci

Dr. Matteo Amicucci

Department of Onco Hematology and Cell and Gene Therapy, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
LRLuisa Russo
Luisa Russo
ATAlberto Eugenio Tozzi
Alberto Eugenio Tozzi
Angela MastronuzziAngela Mastronuzzi
Angela Mastronuzzi
ICIleana Croci
Ileana Croci
FGFrancesco Gesualdo
Francesco Gesualdo
EPElisa Piccinelli
Elisa Piccinelli
Virtual reality (VR) represents a promising digital intervention for managing distress and anxiety in children with tumors undergoing painful medical procedures. In an experimental cross-over study, we administered a VR intervention consisting of relaxing games during central venous catheter (CVC) dressing. The VR sessions were compared with no-VR during CVC medication. We used the distress thermometer and RCMAS-2 scale to assess distress and anxiety levels. We also explored the satisfaction level in patients and families. We enrolled 22 children. The distress levels after medication were lower in the VR group than in those without VR (VR: median 2; IQR 0–2; no-VR: median 4; IQR: 3–5). No variation in anxiety levels was detected by VR intervention. Satisfaction for using VR was very high in children and their families although a total of 12% of children were disappointed by the effect of VR. Most healthcare workers felt that VR would be useful in routine clinical practice. A VR intervention is highly acceptable, may be efficacious in decreasing distress in children with cancer undergoing painful procedures, but it is less likely that it has a measurable impact on anxiety. Evidence from larger studies is needed to assess VR translation into the clinical workflow.

21 November 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Matteo AmicucciMatteo Amicucci
Matteo Amicucci
Angela MastronuzziAngela Mastronuzzi
Angela Mastronuzzi
ICItalo Ciaralli
Italo Ciaralli
FPFederico Piccioni
Federico Piccioni
ASAndreea Cristina Schiopu
Andreea Cristina Schiopu
IDImmacolata Dall'Oglio
Immacolata Dall'Oglio
Despite the fact that cancer patients seem to be at a higher risk of being infected with SARS-CoV-2, limited data are available in the pediatric oncology setting. A systematic rapid review was conducted to analyze scientific literature regarding the management, interventions, and strategies adopted to prevent the spread of COVID-19 in the pediatric cancer population. Our search on PubMed, Scopus, Cochrane, and EMBASE databases yielded 505 articles. After removing duplicates, 21 articles were included. Articles focused on infection prevention (n = 19; 90.5%), management (n = 18; 85.7%), overall management of specific treatments for cancer (n = 13; 61.9%), and education (n = 7; 33.3%). The interventions adopted to prevent the spread of COVID-19 were similar across organizations and in line with general recommendations. Most of them reported interventions that could be used as valid strategies for similar emergencies. The strategies included limiting the risk of contagion by restricting access to the wards and implementing hygiene measures, the identification of separate pathways for the management of patients suspected or confirmed to be infected with COVID-19, the postponement of people accessing the hospital for non-urgent or unnecessary tests or medical examinations, and the preventive screening of patients before chemotherapy treatment or transplantation of hematopoietic stem cells. It is necessary to identify key indicators in order to better evaluate the effectiveness of the interventions implemented over time. A summary of the recommendations is provided.

26 June 2020 in Pediatric Blood & Cancer
Verified
Journal Article
Open access
PDF file
Matteo AmicucciMatteo Amicucci
Matteo Amicucci
MCMarta Canesi
Marta Canesi
ERElena Rostagno
Elena Rostagno
ABAnna Bergadano
Anna Bergadano
CBClara Badino
Clara Badino
MPMoreno Crotti Partel
Moreno Crotti Partel
Click on the article title to read more.

1 January 2021 in Journal of Infusion Nursing
Verified
Journal Article
Closed access
Matteo AmicucciMatteo Amicucci
Matteo Amicucci
ICItalo Ciaralli
Italo Ciaralli
The prognosis of children with acute lymphoblastic leukemia can be improved with the use of monoclonal antibodies such as blinatumomab. Many studies discuss the management and treatment of symptoms; however, none of them describe practical complications related to the continuous infusion of blinatumomab, especially during home-based therapy. The purpose of this study is to describe the experience gained over 4 years in the management of pediatric patients undergoing therapy with blinatumomab in an Italian tertiary hospital. The establishment of a nursing program dedicated to improving infusion pump management, patient support, quality of care, and patient safety will be discussed.

24 March 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GFGiulia Fiumana
Giulia Fiumana
DBDebora Botta
Debora Botta
MPMaria Francesca Dalla Porta
Maria Francesca Dalla Porta
SMSimone Macchi
Simone Macchi
ESElena Soncini
Elena Soncini
Simone CesaroSimone Cesaro
Simone Cesaro
Contact with animals in pediatric oncohematologic patients is associated with many benefits, but the risk of contracting zoonoses, even if low, must be considered by clinicians. In order to assess the awareness about this topic, we surveyed the Italian pediatric oncohematology centers, which resulted in heterogeneous responses. The Infectious Diseases Working Group and the Nurse Working Group of the Italian Association of Pediatric Hematology-Oncology, together with veterinarians from the National Federation of Italian Veterinarians, drew up a consensus document to unify the indications to be given to families with the aim of guaranteeing a safe interaction between patients and animals and improving the collaboration of clinicians with veterinarians and families.

25 December 2023 in European Journal of Oncology Nursing
Verified
Journal Article
Closed access
EFElena Fabbri
Elena Fabbri
ERElena Rostagno
Elena Rostagno
Arianna AcetiArianna Aceti
Arianna Aceti
AZAndrea Zibaldo
Andrea Zibaldo
Matteo AmicucciMatteo Amicucci
Matteo Amicucci